Middle Molecule Find

Rulebook › V-tags › V181

V181 Ultrapure dialysate: bacteria and endotoxin

Written V0181 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD52:2004, adopted by reference at 42 CFR 494.40(a) · Appendix H Rev. 246, page 45 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD52:2004 Requirements as Adopted by Reference 42 CFR 494.40(a)

4.3.2.2 Bacteriology of ultrapure dialysate: Ultrapure dialysate should contain a total viable microbial count lower than 0.1 CFU/mL and an endotoxin concentration lower than 0.03 EU/mL. If those limits are exceeded in ultrapure dialysate, corrective measures should be taken to reduce the levels to an acceptable range. The user is responsible for monitoring the dialysate bacteriology of the system following installation. It is the user's responsibility to establish a regular monitoring routine.

CMS's interpretive guidance

Interpretive Guidance § 494.40(a)

AAMI Rationale for the Development and Provision of This Recommended Practice

A.4.3.2.2 Bacteriology of ultrapure dialysate

Ultrapure dialysate is defined as one having a bacterial content of less than 0.1 CFU/mL and an endotoxin content of less than 0.03 EU/mL. This definition is now widely accepted, particularly in Europe, and the use of ultrapure dialysate is considered a requirement for on-line convective therapies (see AAMI A.4.3.2.3).

Ultrapure dialysate is prepared by sequential ultrafiltration of dialysate prepared from purified water meeting the requirements of AAMI 4.1 and concentrates. Dry powder cartridges are frequently used for the online preparation of bicarbonate concentrate to minimize the potential for the concentrate to contribute high levels of bacteria and endotoxin to the dialysate.

Additional Guidance:

The sensitivity and specificity of the test assay significantly impact the accuracy and subsequent interpretation of test results. Users should select assays that are sensitive to the test being performed.

At the time of publication of these regulations (April 15, 2008, 73 FR 20369), most dialysis facilities in the U.S. were using conventional dialysate, rather than ultrapure dialysate. The use of conventional or ultrapure dialysate is a clinical decision made by the ordering physician. There is no Federal requirement to use ultrapure dialysate.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 45 (the full 469-page PDF) before quoting it.